
Sign up to save your podcasts
Or


For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/QKQ865. CME/MOC/AAPA credit will be available until December 7, 2026.
Toward Functional Cure in Chronic HBV: Monitoring, Serological Markers, and Evolving Therapy
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This educational activity is supported by an independent medical education grant from GSK.
Disclosure information is available at the beginning of the video presentation.
By PVI, PeerView Institute for Medical Education4.1
2525 ratings
For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/QKQ865. CME/MOC/AAPA credit will be available until December 7, 2026.
Toward Functional Cure in Chronic HBV: Monitoring, Serological Markers, and Evolving Therapy
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This educational activity is supported by an independent medical education grant from GSK.
Disclosure information is available at the beginning of the video presentation.

43,673 Listeners

136 Listeners

316 Listeners

696 Listeners

497 Listeners

29 Listeners

11 Listeners

1,385 Listeners

5 Listeners

11 Listeners

3 Listeners

2 Listeners

5 Listeners

2 Listeners

3 Listeners

5 Listeners

5 Listeners

2 Listeners

0 Listeners

9 Listeners

2 Listeners

12 Listeners

2 Listeners

883 Listeners

4 Listeners

3 Listeners

5 Listeners

3,346 Listeners

1,147 Listeners

193 Listeners

94 Listeners

514 Listeners

367 Listeners

428 Listeners